The aim of this study is to investigate brain-predicted age, brain-predicted age gap (the difference between brain-predicted age and chronological age), and brain tissue volume changes in Multiple Sclerosis (MS) patients compared to healthy controls (HCs) to better understand and characterize the neurodegenerative burden of the disease.
Bao et al. (Tue,) studied this question.